Senhwa Biosciences’ Pidnarulex joins forces with global PD-1 leaders to advance next-gen immunotherapy
This strategic collaboration represents the third clinical trial under Senhwa’s five-year NCI-sponsored cancer research program
This strategic collaboration represents the third clinical trial under Senhwa’s five-year NCI-sponsored cancer research program
Subscribe To Our Newsletter & Stay Updated